Alliance Pharma Share Price | |
---|---|
Price | 86.30 |
Bid | 86.20 |
Ask | 86.70 |
Change | 0.00 (0.00%) |
Volume | 475,649 |
Open | 87.50 |
High | 87.70 |
Low | 86.10 |
Close | 86.30 |
Currency | GBX |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 533m |
Market Capitalisation | £460m |
Market Size | 15,000 |
52 Week High | 90.90 |
52 Week High Date | 04-Jan-2021 |
52 Week Low | 57.10 |
52 Week Low Date | 23-Mar-2020 |
# Trades | 379 |
---|---|
Vol. Sold | 209,051 |
Sold Value | £180.41k |
Vol. Bought | 239,638 |
Bought Value | £206.81k |
PE Ratio | 17.979 |
Earnings | 4.80 |
Dividend | 0.536 |
Yield | 0.621% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
15-Jan-21 | 17:44:15 | 86.594 | 13,951 | Buy* | 86.20 | 86.70 | 12.08k | O Ordinary |
15-Jan-21 | 16:35:13 | 86.30 | 77,523 | Sell* | 86.20 | 86.70 | 66.90k | UT Uncrossing Trade |
15-Jan-21 | 16:29:46 | 86.70 | 200 | Buy* | 86.20 | 86.70 | 173.40 | A Automatic Execution |
15-Jan-21 | 16:29:45 | 86.70 | 430 | Buy* | 86.20 | 86.70 | 372.81 | A Automatic Execution |
15-Jan-21 | 16:29:45 | 86.70 | 122 | Buy* | 86.20 | 86.70 | 105.77 | A Automatic Execution |
15-Jan-21 | 16:29:13 | 86.70 | 230 | Buy* | 86.20 | 86.70 | 199.41 | A Automatic Execution |
15-Jan-21 | 16:28:30 | 86.50 | 457 | Buy* | 86.20 | 86.70 | 395.31 | A Automatic Execution |
15-Jan-21 | 16:28:30 | 86.50 | 616 | Buy* | 86.20 | 86.70 | 532.84 | A Automatic Execution |
15-Jan-21 | 16:28:30 | 86.50 | 1,252 | Buy* | 86.10 | 86.50 | 1,083 | A Automatic Execution |
15-Jan-21 | 16:28:25 | 86.40 | 199 | Buy* | 86.10 | 86.50 | 171.94 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
26-Jun-20 | 23-Jun-20 | Buy | David Cook held the position of Non-Executive Chairman at the time of this trade. David Cook | 77.70 | GBX | 63,879 | 234,129 |
26-Jun-20 | 23-Jun-20 | Buy | David Cook held the position of Non-Executive Chairman at the time of this trade. David Cook | 77.70 | GBX | 63,879 | 166,250 |
11-May-20 | 07-May-20 | Sell | Peter Butterfield held the position of CEO at the time of this trade. Peter Butterfield | 7,470.00 | GBX | 161,915 | 412,461 |
11-May-20 | 07-May-20 | Exercise of option | Peter Butterfield held the position of CEO at the time of this trade. Peter Butterfield | 4,750.00 | GBX | 200,000 | 412,461 |
05-Dec-19 | 05-Dec-19 | Sell | Andrew Franklin held the position of CFO at the time of this trade. Andrew Franklin | 76.90 | GBX | 1,371,616 | 128,384 |
Our expertise lies in the acquisition and licensing of pharmaceutical and healthcare products and delivering these to patients